|
Real-time Estimate
Cboe BZX
20:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 137.66 USD | -3.47% |
|
-3.45% | +357.49% |
| 08-28 | BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall | MT |
| 08-28 | FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- MRNA Stock
- MRNA_KZ Stock
- Consensus Moderna, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
